(NASDAQ: GLTO) Galecto's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.
Galecto's earnings in 2025 is -$18,495,000.On average, 1 Wall Street analyst forecast GLTO's earnings for 2025 to be -$14,612,067, with the lowest GLTO earnings forecast at -$14,612,067, and the highest GLTO earnings forecast at -$14,612,067. On average, 1 Wall Street analyst forecast GLTO's earnings for 2026 to be -$3,887,735, with the lowest GLTO earnings forecast at -$3,887,735, and the highest GLTO earnings forecast at -$3,887,735.
In 2027, GLTO is forecast to generate -$3,253,003 in earnings, with the lowest earnings forecast at -$3,253,003 and the highest earnings forecast at -$3,253,003.